SOLITARY LUNG LESIONS: CURRENT PROBLEMS OF DIAGNOSIS AND TREATMENT

Solitary lung lesions are among the most frequently detected clinico-radiological problems in modern med­icine, largely due to the widespread use of chest computed tomography (CT) and lung cancer screening. Although the majority of solitary pulmonary nodules are benign, some may represent an early manifestation of primary lung cancer. Therefore, the main objective of the diagnostic strategy is to achieve a balance between two opposing risks: on the one hand, to avoid unnecessary investigations, invasive biopsy, and unwarranted surgical interventions for benign lesions; and on the other hand, to prevent underestimation of malignant lesions, failure to adhere to recom­mended follow-up, and delays in the diagnosis of lung cancer. This article is devoted to an analysis of the major challenges in the diagnosis and treatment of solitary lung lesions based on contemporary scientific literature, expert consensus statements, and clinical recommendations pub­lished between 2022 and 2026. Currently, CT remains the primary method for detecting solitary pulmonary nodules, their initial assessment, and longitudinal follow-up. Nodule size, density, margin characteristics, location, calcification, and growth dynamics, as well as the patient's age, smoking history, and oncological history, are important factors in assessing the risk of malignancy. PET/CT and morphological examination can help refine the diagnostic algorithm in patients with high or intermediate risk. However, invasive procedures may be associated with pneumothorax, bleed­ing, and other complications. At the same time, loss to follow-up or failure to reassess CT findings in a timely manner may result in delayed detection of lung cancer and disease progression. Thus, the optimal strategy for managing patients with solitary lung lesions is not to pursue “more testing,” but rather to accurately assess the level of risk, implement standardized follow-up, perform minimally invasive mor­phological evaluation when indicated, and apply a multidisciplinary approach.

Authors

Institutions

Publication Details

Journal
Journal of modern medicine
Published
2026-09-17
DOI
https://doi.org/10.67519/nshr.ztj.2026.14.148
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

SOLITARY LUNG LESIONS: CURRENT PROBLEMS OF DIAGNOSIS AND TREATMENT

N.N. Nazarov
Journal of modern medicine
Lung Cancer Diagnosis and Treatment
article

SOLITARY LUNG LESIONS: CURRENT PROBLEMS OF DIAGNOSIS AND TREATMENT

N.N. Nazarov
article en

Abstract

Solitary lung lesions are among the most frequently detected clinico-radiological problems in modern med­icine, largely due to the widespread use of chest computed tomography (CT) and lung cancer screening. Although the majority of solitary pulmonary nodules are benign, some may represent an early manifestation of primary lung cancer. Therefore, the main objective of the diagnostic strategy is to achieve a balance between two opposing risks: on the one hand, to avoid unnecessary investigations, invasive biopsy, and unwarranted surgical interventions for benign lesions; and on the other hand, to prevent underestimation of malignant lesions, failure to adhere to recom­mended follow-up, and delays in the diagnosis of lung cancer. This article is devoted to an analysis of the major challenges in the diagnosis and treatment of solitary lung lesions based on contemporary scientific literature, expert consensus statements, and clinical recommendations pub­lished between 2022 and 2026. Currently, CT remains the primary method for detecting solitary pulmonary nodules, their initial assessment, and longitudinal follow-up. Nodule size, density, margin characteristics, location, calcification, and growth dynamics, as well as the patient's age, smoking history, and oncological history, are important factors in assessing the risk of malignancy. PET/CT and morphological examination can help refine the diagnostic algorithm in patients with high or intermediate risk. However, invasive procedures may be associated with pneumothorax, bleed­ing, and other complications. At the same time, loss to follow-up or failure to reassess CT findings in a timely manner may result in delayed detection of lung cancer and disease progression. Thus, the optimal strategy for managing patients with solitary lung lesions is not to pursue “more testing,” but rather to accurately assess the level of risk, implement standardized follow-up, perform minimally invasive mor­phological evaluation when indicated, and apply a multidisciplinary approach.

Journal of modern medicineVol. 3(14)
Aerospace Medical Association (US)
Good health and well-being
Openalex Percentile: Top 12%
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

SOLITARY LUNG LESIONS: CURRENT PROBLEMS OF DIAGNOSIS AND TREATMENT — N.N. Nazarov · Journal of modern medicine (2026) | TGRS Research Map | TGRS